Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Number of holders
-
277
-
Total 13F shares, excl. options
-
38,678,079
-
Shares change
-
-2,180,324
-
Total reported value, excl. options
-
$3,475,093,026
-
Value change
-
-$190,434,872
-
Put/Call ratio
-
95%
-
Number of buys
-
124
-
Number of sells
-
-114
-
Price
-
$89.87
Significant Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q3 2024
329 filings reported holding AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2024.
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) has 277 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38,678,079 shares
of 48,932,355 outstanding shares and own 79% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (4,189,557 shares), VANGUARD GROUP INC (3,995,345 shares), BlackRock, Inc. (3,398,379 shares), Fairmount Funds Management LLC (2,360,077 shares), FMR LLC (1,088,087 shares), BVF INC/IL (1,046,000 shares), RA CAPITAL MANAGEMENT, L.P. (1,000,000 shares), MACQUARIE GROUP LTD (995,287 shares), STATE STREET CORP (916,808 shares), and GEODE CAPITAL MANAGEMENT, LLC (908,459 shares).
This table shows the top 277 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.